Bayer CropScience Buys Athenix For $365M

Law360, New York (November 4, 2009, 5:27 PM EST) -- Germany-based Bayer CropScience AG has completed its $365 million acquisition of biotechnology company Athenix Corp., a portfolio company of private equity firm Boston Millennia Partners.

Bayer CropScience said Monday that it had bought Athenix for $365 million, with further cash payments of up to $35 million to be paid based on the achievement of certain development milestones.

“We are investing heavily in our BioScience business to strengthen our position in the global seeds and traits market,” said Friedrich Berschauer, chairman of the board of management of...
To view the full article, register now.